Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P‐TIMI 50

BACKGROUND: Patients with stable atherothrombotic disease vary in their risk of developing heart failure (HF). Circulating cardiovascular biomarkers may improve HF risk assessment and identify patients who may benefit from emerging HF preventive therapies. METHODS AND RESULTS: We measured high‐sensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Berg, David D., Freedman, Benjamin L., Bonaca, Marc P., Jarolim, Petr, Scirica, Benjamin M., Goodrich, Erica L., Sabatine, Marc S., Morrow, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200769/
https://www.ncbi.nlm.nih.gov/pubmed/33884889
http://dx.doi.org/10.1161/JAHA.120.018673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200769/
https://www.ncbi.nlm.nih.gov/pubmed/33884889
http://dx.doi.org/10.1161/JAHA.120.018673

Ejemplares similares